Breaking News on Laboratory Equipment |
| « Previous month | Next month » |
The norovirus, a highly contagious source of food poisoning, has been successfully grown in the lab for the first time, report US researchers.
Food safety reaffirmed with infant foods in the UK strapped into the legal limits for fungal contamination, finds a recent survey from the UK's food watchdog.
Affymetrix has extended the range of custom microarrays by launching a host of prokaryotic array designs, which offer scientists an affordable tool to conduct whole-genome expression studies on a wide range of pathogenic organisms.
Bioengineers at the University of Oxford have developed a solution to the problem of toxicity testing for new drugs, which can prove to be ineffective or at worst dangerous to humans.
A technique that uses crystals to map 'invisible' parts of molecules is set to revolutionise drug discovery by allowing the molecular structures of proteins to be studied in greater detail advancing on the technique of protein crystallography.
After a successful trial period, Syrris has supplied one of its recently-launched AFRICA microreactor systems to Professor Steven Ley at the Department of Chemistry at the University of Cambridge, UK. His group will use the system to develop new techniques to advance flow chemistry.
High throughput protein (HTP) crystallography is set to undergo key technical developments in which the development of automation in protein expression, protein engineering and crystallisation will provide the accurate screening data that has proved elusive to date.
German microfluidics company ThinXXS is to exhibit its novel modular design system, the microfluidic construction kit, a lab-on-a-chip (LOC) device that enables researchers to configure required chip functions. The feature is sure to impact on the high-throughput screening of drug candidates, point of care testing and bioinformatics.
The Lab Automation Europe show at London's Kensington Olympia showcased the latest laboratory equipment and technological developments which are featured in a round-up of new apparatus that could prove useful in drug discovery.
Freeman Technology has launched the first in its range of 'plug and play' accessories that will automate powder flow testing on the company's FT4 Powder Rheometer, after adding in a shear test function earlier this year.
Applying automation to tissue culture techniques can improve the development, maintenance and expansion of mammalian cells, increasing the efficiency of drug discovery efforts, reports Wai Lang Chu.
The Lab Automation Europe show held earlier this week saw Thermo unveil a number of new products, including a new spectral scanner that can handle all wavelengths, without needing filters, and has an integrated dispenser for reagents.
An inconclusive BSE test has been recorded in the US, but the government is insisting that there is no cause for alarm.
LION bioscience has said it plans to cut its headcount by at least 50 per cent as part of a new restructuring drive, with most cuts being felt at the company's facilities in Heidelberg, Germany.
Caliper Life Sciences has launched a new automated electrophoresis system that offers researchers a viable alternative to slab gel electrophoresis on a small microfluidic chip that is set to greatly increase sample throughput leading to a more efficient identification of new targets for drug development.
A new system that offers both pressure loss measurement and packaging seal strength has been launched.
France-based research laboratory, Spincontrol is launching a new technology to test skin whitening technologies. The development is claimed to provide proven efficacy of whitening products for ageing Caucasian skins as well as Asian skins.
A laboratory test that is able to detect methicillin resistant Staphylococcus aureus (MRSA) a day earlier then traditional antimicrobial susceptibility testing (AST) gives fresh impetus to treatment and infection control efforts that have been previously hampered.
Argonaut Technologies has announced the introduction of EVOLUTE ABN (Acidic Basic Neutral), a product that extracts drugs from biological fluids through improved phase extraction.
Exiqon has launched two new ProbeLibrary expression analysis kits, covering the genomes of Arabidopsis thaliana and Drosophila melanogaster, the most widely used models in disease process and drug target studies.
Sweden's Cellectricon has launched a new microfluidic chip product that promises to speed up the screening of drugs that interact with ion channels, an important drug target that make up around 15 per cent of all medicines on the market.
Setting aside the acrimony of a patent dispute, UK separations company Whatman is to buy German rival Schleicher & Schuell for €50.2 million, allowing it to narrow the gap between itself and the main players Pall and Millipore.
EU health commissioner David Byrne has expressed his confidence in the food chain as a contamination scare highlights the value of traceability and the progress made in reducing risks to the complex food production industry.
UK researchers have developed a technique that could be used to analyse membrane proteins, capturing them in their natural structural state to make it easier to develop drug candidates to target them.
The major laboratory supply companies in the US have a mixed bag of results in the third quarter of 2004, with exceptional items eating into profits as a consequence of M&A activity and restructuring, reports Phil Taylor.
LION's strategy to move towards the informatics sector, shifting the focus away from the drug development sector seems to be gaining momentum as second quarter net losses were reduced to €3.4million compared to €6.5 million in Q2 2003. The result was in line with interim projections.
According to a report, it takes 7-10 years to develop and market a drug with costs exceeding $800 million (€625 million). This revelation is set to add to the pressure already facing pharmaceutical and biotechnology companies which are already feeling the strain to produce a steady stream of innovative, well-differentiated drugs at reduced costs
Agilent Technologies has launched what it claims is the industry's first fully automated, high-throughput 'lab-on-a-chip system' for basic life science research and drug discovery. The Agilent 5100 Automated provides unattended analysis of thousands of DNA and protein samples per day.
MatriCal has introduced its SonicMan sonication system to the European compound management market with versions that can handle 384- as well as 96-well microwell plate formats.
Charles River Laboratories third quarterly performance in the third quarter of 2004 reflected the current market climate for products and services that support the drug discovery and development process, with notable increases in operating income and earnings per share.
Separation and filtration giant Pall is to pay $32 million to acquire BioSepra, a division specialising in protein purification technologies, from Ciphergen.
Cambrex has recorded a loss in the third quarter of this year after writing down goodwill in its biopharma division in a move that paints a pessimistic picture of the market for outsourced manufacturing of biological drugs.
| « Previous month | Next month » |